Pharmaceuticals Industry of Bangladesh
Domestic market of Pharmaceutical products in Bangladesh has shown an increasing trend over the past few years and the market size is BDT 187,566 million as on 2017 Q2 (Source: IMS Health Report Q2). According to Bangladesh Bureau of Statistics, the industry has contributed 1.85% to the GDP in 2016-17 . Pharmaceutical industry of Bangladesh is largely protected from external competition, as there is a restriction regarding import of similar drugs that is manufactured locally. This industry is the second largest contributor to national exchequer. At the same time, the industry provides the largest white collar (note) intensive employment.
EBL Securities PLC. (EBLSL) is one of the fastest growing full-service institutional brokerage companies in Bangladesh. On top of our expertise and achievements, we take pride in our strong commitment towards excellent client services and development of the Bangladesh capital markets.
EBLSL is a fully owned subsidiary of Eastern Bank PLC.(EBL), one of the leading private commercial banks of Bangladesh. EBLSL is one of the TOP-10 brokerage companies of Bangladesh.
We have unwavering faith in the potential of Bangladesh. We also believe that an efficient, vibrant and transparent capital market can strongly contribute to the overall development of Bangladesh. Bangladesh is currently at the initial stage of capital market growth, and we are committed to assist the entry of early movers into a growth-oriented, vibrant, nascent emerging market.
EBLSL has developed a disciplined approach towards providing capital market services. The foundation for our business is a strong commitment towards market experience & professionalism, investment knowledge, market intelligence and research services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.